TY  - JOUR
AU  - Sanoja-Flores, L
AU  - Flores-Montero, J
AU  - Garcés, J J
AU  - Paiva, B
AU  - Puig, N
AU  - García-Mateo, A
AU  - García-Sánchez, O
AU  - Corral-Mateos, A
AU  - Burgos, L
AU  - Blanco, E
AU  - Hernández-Martín, J
AU  - Pontes, R
AU  - Díez-Campelo, M
AU  - Millacoy, P
AU  - Rodríguez-Otero, P
AU  - Prosper, F
AU  - Merino, J
AU  - Vidriales, M B
AU  - García-Sanz, R
AU  - Romero, A
AU  - Palomera, L
AU  - Ríos-Tamayo, R
AU  - Pérez-Andrés, M
AU  - Blanco, J F
AU  - González, M
AU  - van Dongen, J J M
AU  - Durie, B
AU  - Mateos, M V
AU  - San-Miguel, J
AU  - Orfao, A
AU  - EuroFlow consortium
PY  - 2018
DO  - 10.1038/s41408-018-0153-9
UR  - http://hdl.handle.net/10668/13210
T2  - Blood cancer journal
AB  - Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using next-generation flow...
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers
KW  - Diagnosis, Differential
KW  - Female
KW  - Flow Cytometry
KW  - Humans
KW  - Immunophenotyping
KW  - Male
KW  - Middle Aged
KW  - Monoclonal Gammopathy of Undetermined Significance
KW  - Multiple Myeloma
KW  - Neoplasm Staging
KW  - Neoplastic Cells, Circulating
KW  - Plasma Cells
KW  - Prognosis
KW  - Sensitivity and Specificity
TI  - Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).
TY  - research article
VL  - 8
ER  -